Anti-HIV drug combination gets FDA approval
January 08 2004 1:00 AM ET
The Food and Drug Administration on Tuesday approved a supplemental new drug application by Roche for the combined use of its protease inhibitor Invirase with a booster dose of Abbott Laboratories' protease inhibitor Norvir. Both Norvir and Invirase have previously been approved separately to treat HIV disease. However, Invirase, the first protease inhibitor ever approved by the FDA, is rarely used in HIV therapy because in its unboosted form it fails to reach adequate levels in the bloodstream. Roche began marketing an improved version of Invirase, called Fortovase, in 1997. New studies by the company showed that a 1,000-milligram Invirase/100-milligram Norvir combination is as effective in reducing HIV viral loads as treatment with Fortovase. The medications will be dosed in five capsules taken twice per day within two hours of eating. Company officials say Invirase should not be taken without a booster dose of Norvir because the drug when used alone is ineffective in slowing or preventing the spread of HIV in the body.
- Anne Rice Announces New Vampire Chronicles Novel
- Op-ed: What People Don't Get About Dismay Over Jared Leto
- Pet Shop Boys Remix Irish Drag Queen's Powerful Speech Against Homophobia
- Is Mr. Peabody & Sherman About Adoption by Gays?
- WATCH: Gay Man's Grandfather Came Out to Him at 90 Years Old
- Op-ed: Pope Francis: One Year In, Door Slightly Ajar for LGBT People
- Current Issue Editor’s Letter: April/May Issue 57 min 55 sec ago
- Parenting Is Mr. Peabody & Sherman About Adoption by Gays? 1 hour 59 min ago
- Media Former Fox Sportscaster Claims Anti-Antigay Discrimination March 10 2014 9:37 PM
- Women Lorde Takes Down Idiot DJ Who Implies She and Taylor Swift Are Lesbians March 10 2014 9:01 PM
- Women WATCH: Trailer for New Lesbian-Themed Series #Hashtag March 10 2014 7:54 PM
- Travel Sydney Mardi Gras: A Post-Mortem March 10 2014 7:47 PM
- Marriage Equality WATCH: Marriage Equality Is an 'Extra Right,' Says Right-Wing Activist March 10 2014 7:44 PM